Results 71 to 80 of about 15,436 (169)

Early‐Onset Wild‐Type Transthyretin Amyloidosis Polyneuropathy

Muscle &Nerve, Volume 74, Issue 5, Page 1471-1475, November 2026.
Chafic Karam, Kaylee Baker, Sami Khella, Brian Drachman, Pranav Chandrashekar, MacLean Nasrallah, Shunsuke Koga, Janice Pieretti   +7 more
wiley   +1 more source

Health Care Resource Utilization in Transthyretin Amyloid Cardiomyopathy Compared With Non‐amyloid Heart Failure and the General Population

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Transthyretin amyloid cardiomyopathy (ATTR‐CM) is a progressive, fatal disease associated with a substantial health care system burden.
Justin L. Grodin, Ahmad Masri, Richard Wright, Jean‐François Tamby, Heather Falvey, Liana Hennum, Margarita Udall, Chaitanya Badwe, Melissa Allison, Rakesh Ramesh, Shradha Sanghi, Sandesh Dev, Jose Nativi‐Nicolau   +12 more
doaj   +1 more source

Wild-Type Transthyretin Amyloid Cardiomyopathy With Positive

JACC: Case Reports
Background: Wild-type transthyretin amyloid cardiomyopathy (wtATTR-CM) is increasingly recognized with advances in noninvasive imaging and disease-modifying therapies.
Aya Elalfy, DO, Zeyad Kholeif, MD, Rana Rashwan, MD, Carlos Vergara Sanchez, MD, Awais Malik, MD   +4 more
doaj   +1 more source

Prevalence of Isolated Atrial Amyloidosis in Young Patients Affected by Congestive Heart Failure

The Scientific World Journal, 2012
Atrial natriuretic peptide (ANP), whose amyloid is responsible of isolated atrial amyloidosis (IAA), is known to play an important role in the pathophysiology of congestive heart failure (CHF).
Lia Millucci, Lorenzo Ghezzi, Giulia Bernardini, Daniela Braconi, Piero Tanganelli, Annalisa Santucci   +5 more
doaj   +1 more source

The Red Flags Were Missing, the Indication Was Not: Genetic Testing in Heart Failure and Cardiomyopathy

Methodist DeBakey Cardiovascular Journal
Genetic testing is the step most often omitted once a cardiomyopathy has been characterized and the step most often misapplied when it is extended to people who have no phenotype.
Abou Bakr Salama
doaj   +1 more source

Amyloid Cardiomyopathy ∗

Journal of the American College of Cardiology, 2016
Merrill D, Benson, Noel R, Dasgupta
openaire   +2 more sources

Systemic Amyloidosis With Probable Cardiac Involvement: Diagnostic Approach in a Resource‐Limited Setting: A Case Report

Clinical Case Reports
Systemic amyloidosis, which may involve the heart as an infiltrative cardiomyopathy, is frequently underdiagnosed, particularly in low‐resource settings where access to advanced imaging and laboratory investigations for amyloid subtyping is limited.
Malegna Temesgen Garuma, Yonatan Debebe Regassa, Sifessa Dessalegn Demshasha   +2 more
doaj   +1 more source

Systemic amyloid A amyloidosis of the bladder after transurethral resection of urothelial carcinoma

IJU Case Reports
Introduction Amyloid A amyloidosis of the bladder is not a major disease. We report a patient with systemic amyloid A amyloidosis of the bladder after transurethral resection of urothelial carcinoma.
Kaori Yamashita, Keita Yoshida, Tadao Nakazawa, Satoshi Kubota, Takahiro Shiseki, Eri Sekido, Masashi Inui   +6 more
doaj   +1 more source

HYPERTROPHIC CARDIOMYOPATHY MIMICKING AMYLOID CARDIOMYOPATHY

Journal of the American College of Cardiology, 2021
Syed Bukhari, Ricardo Nieves, Shumail Fatima, Arun Iyer, Prem Soman   +4 more
openaire   +1 more source

Cerebrovascular Involvement in Transthyretin Amyloid Cardiomyopathy

Journal of Clinical Medicine
Background: Intracardiac thrombosis is common in transthyretin amyloid cardiomyopathy (ATTR-CM), and patients are at risk for thromboembolic events. However, silent cerebral infarcts and the extent of cerebral small vessel disease in patients with cardiac amyloidosis are unknown.
Lukas Haider, Lore Schrutka, Emanuele Tommasino, Nicolas Avanzini, Sven Hauck, Nikolaus Nowak, Christian Hengstenberg, Diana Bonderman, Majda Thurnher   +8 more
openaire   +2 more sources